MarketInOut Stock Screener Log In | Sign Up

RTW Biotech Opportunities Ltd

LSE • Financial Services • Asset Management • Quote as of 10/27/2026 16:35
RTW Biotech Opportunities Ltd stock price and volume chart

Company Profile

IndustryAsset Management
SectorFinancial Services
ExchangeLSE
Market Capitalization748.26 mln
Float238 mln
Earnings Date03/30/2027

EPS

1.36
Decent

P / E

1.74
Deeply undervalued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

0.63
Highly suspicious

Relative Strength

91 / 100
Top performer

Debt / Equity

0.23
Very low leverage

Business Description

RTW Biotech Opportunities Ltd puts money into early-stage healthcare companies with the potential to change how diseases are treated. Its focus spans drug development, biotechnology, and medical devices, with a particular interest in breakthroughs that could make a real difference for patients.

Key Fundamentals

EPS1.36
P/E1.74
ROE59.78
RPS0.42
ROIC38.68
ROA43.39
Interest Cover59.90
EBITDA, mln463
EV / EBITDA2.26
EV / EBIT2.26
Revenue, mln182
EV / Revenue5.75

Quote Details

Last 2.39
Change 0.06 (2.58%)
Open 2.33
Volume 289,704
Turnover 692,393
Average Volume 317,877

Financial Ratios

Pre-Tax Profit Margin250
Leverage Ratio1.42
Current Ratio0.19
Price / Book0.74
Price / Tangible Book0.74
Price / Cash Flow10.82
Price / Free Cash Flow11.20
Debt / Equity0.23
Price / Sales4.16

Financial Strength

Altman Z-Score3.05
Piotroski F-Score 8 / 9
Beneish M-Score0.63
Price to Intrinsic Value1.27
Price to Graham Number0.23

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.75% 95 / 100   
1 Month 2.14% 79 / 100   
2 Months -3.63% 29 / 100   
6 Months 11.16% 77 / 100   
1 Year 35.8% 88 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog